Navigation Links
AbbVie Issues Inaugural Full-Year Outlook for 2013
Date:1/30/2013

fficer; and Larry Peepo , vice president of investor relations. The call will be webcast through AbbVie's Investor Relations website at www.abbvieinvestor.com. An archived edition of the call will be available after 11 a.m. Central time.

Key Product Performance:The following is a summary of fourth-quarter 2012 sales for select AbbVie products.% Change vs. 4Q11Sales ($ in millions)Int'lTotalU.S.Int'lTotalU.S.OperationalReportedOperationalReportedHUMIRA

1,4131,2682,68131.117.915.224.523.1TRILIPIX/TriCor 

202--202(50.7)n/an/a(50.7)(50.7)AndroGel

364--36440.5n/an/a40.540.5Kaletra

83167250(17.0)(9.4)(11.4)(12.1)(13.4)Lupron

1555621111.3(17.4)(18.1)1.81.6Niaspan

277--2777.4n/an/a7.47.4Synthroid

168--16824.9n/an/a24.924.9Creon

105--1053.9n/an/a3.93.9The following is a summary of twelve-month 2012 sales for select AbbVie products.% Change vs. 12M11Sales ($ in millions)Int'lTotalU.S.Int'lTotalU.S.OperationalReportedOperationalReportedHUMIRA

4,3764,8899,26527.715.48.520.716.8TRILIPIX/TriCor

1,098--1,098(19.9)n/an/a(19.9)(19.9)AndroGel

1,152--1,15231.7n/an/a31.731.7Kaletra

2807331,013(14.1)(7.6)(13.2)(9.4)(13.4)Lupron

5692318005.4(10.5)(14.4)0.1(1.2)Niaspan

911--911(6.7)n/an/a(6.7)(6.7)Synthroid

551--5515.7n/an/a5.75.7Creon

353--3536.5n/an/a6.56.5Note:  "Operational" growth reflects percentage change over the prior year excluding the impact of exchange rates.

About AbbVie
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott.  With its 125-year history, the company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases.  In 2013, AbbVie
'/>"/>

SOURCE AbbVie
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AbbVie Named to S&P 500 Dividend Aristocrat Index
2. Emmaus Life Sciences Issues Statement in Response to Announcement by AFH Holding & Advisory
3. Qualitest Issues Voluntary, Nationwide Recall of 101 Lots of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg Due to the Potential for Oversized Tablets
4. Fero Industries, Inc. Issues Corporate Update
5. CSL Behring Parent Company, CSL Limited, Issues Fourth Corporate Responsibility Report
6. Ranbaxy Issues Voluntary Nationwide Recall of 41 lots of Atorvastatin Calcium Tablets 10 mg, 20 mg and 40 mg Due to Potential Presence of Foreign Substance
7. Emmaus CEO Yutaka Niihara, M.D., Issues Statement In Connection with Status of Companys Phase III FDA Sickle Cell Treatment Trials
8. Zi Xiu Tang Success, LLC Issues Voluntary Nationwide Recall of Classic Zi Xiu Tang Bee Pollen Capsules and Ultimate Formula Capsules due to Undeclared Sibutramine
9. CORRECTION: Star Scientific Issues Statement Correcting the Underreporting of the "Flint" CRP Human Study Results
10. Qualitest Issues Voluntary, Nationwide Recall for One Lot of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg Due to the Potential for Oversized Tablets
11. Sun Pharmaceutical Industries, Inc. Issues Nationwide Voluntary Recall of One Lot of Nimodipine Capsules due to Crystallization of the Fill Material
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... REDMOND, Wash. , July 28, 2015 ... ingestion of Nutraceutix,s L. reuteri probiotic enriches ... factors that increase insulin secretion.  The study involved daily ... strain SD-5865) in tablets using the patented BIO- tract ... from damage by stomach acid on their way to ...
(Date:7/28/2015)...  SeraCare Life Sciences, a leading partner to ... the American Association of Clinical Chemistry (AACC) meeting ... the University of California, San Francisco (UCSF) for ... (T18) and Trisomy 13 (T13) trophoblast cell line ... materials for Non-Invasive Prenatal Testing (NIPT) of chromosomal ...
(Date:7/28/2015)... 2015 The Physician-Patient Alliance for Health & ... " Surviving Your Hospital Stay ." "Help ... None of these patients went home from hospital," said ... PPAHS) referring to the patient stories presented ... to Promote Continuous Monitoring of Patients on Opioids ...
Breaking Medicine Technology:Nutraceutix's L. reuteri Probiotic Clinically Proven to Modulate Gut Insulin Metabolism 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 3Surviving Your Hospital Stay: Physician-Patient Alliance for Health & Safety Launches Fundraising for Patient Safety 2
... Sept. 7 Epeius Biotechnologies Corporation, a leader in ... publication of a landmark paper in clinical oncology. Following ... of Rexin-G in chemo-resistant metastatic pancreatic cancer ( Molecular ... Drug and FDA Fast Track Status, this new paper ...
... India, Sept. 7 Sun Pharmaceutical Industries Ltd. (Sun) ... today announced that the Supreme Court of Israel has ... (Taro) (Pink Sheets: TAROF ) of the ... the Israeli special tender offer (STO) rules do not ...
Cached Medicine Technology:To Reach, Perchance to Kill the Cancer: A Soliloquy From Epeius Nanotechnologies Opposes That 'Sea of Troubles' 2Supreme Court of Israel Rules in Favor of Sun Pharma 2Supreme Court of Israel Rules in Favor of Sun Pharma 3
(Date:7/28/2015)... ... , ... City Sports, a specialty sports retailer and a premiere destination for ... CEO. , Hanaka, who has served on the Board of Directors for City Sports ... Consumer Fund has had previous tenures as Chairman and CEO of Golfsmith International Holdings, ...
(Date:7/28/2015)... ... July 28, 2015 , ... ProFont is back with a whole ... With ProFont: Cursive users can generate a hand drawn feel all with a click ... Users can select from either the upper and lowercase alphabet, special characters, numbers, and ...
(Date:7/28/2015)... ... 28, 2015 , ... World Patent Marketing, a vertically integrated ... cleans pools efficiently - minus the backbreaking work. , "The Swimming Pool Cleaning ... of World Patent Marketing. "It is a sleeping giant that has woken up ...
(Date:7/28/2015)... FL (PRWEB) , ... July 28, 2015 , ... ... and The Miriam Hospital examines outcomes for inmates who continued methadone maintenance treatment ... latter group was more likely to relapse to opiate use (1) and more ...
(Date:7/28/2015)... ... , ... By 2016, the number of smartphones worldwide will surpass 2 billion. ... highly personal basis, increasing customer loyalty. However, capitalizing on this is not always obvious. ... to more nimble competitors. , The Open Mobile Summit 2015 is an influential gathering ...
Breaking Medicine News(10 mins):Health News:City Sports Names Marty Hanaka CEO 2Health News:Announcing ProFont Cursive from FCPX Effects developer Pixel Film Studios 2Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 2Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 3Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 4Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 5Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 4Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 2Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 3
... the use of conditioning regimens of non-myeloablative ... toxic effects extends the possibility of hematopoietic-cell// ... and those with coexisting conditions. ... major problem after non-myeloablative transplantation. Death due ...
... Professor Ashley Woodcock and his team from the University of ... the pillows they analyzed. These fungi act as a trigger ... reported in the Journal Allergy. Researchers collected samples from 5 ... Researchers found that all the 10 pillows studied had a ...
... the deadly HIV/AIDS is accelerating in China with 126,808 ... patients, according to latest health reports//. Experts estimate that ... 80,000 AIDS patients. ,This is considerably higher than the ... over a margin of 19,818. In addition, the patients ...
... the first home based rapid HIV strip test kit. The result ... test without any physician or clinician help//. This new OraQuick test ... go public after FDA approval. This is a strip test, in ... two lines implies infection and the person is positive for HIV. ...
... associated with many adverse health consequences. The rapid ... population emphasizes the importance of environmental factors on ... make up one environmental component that has been ... the eating behaviors of children in a variety ...
... been designated as the National Dental Hygiene Month (NDHM) ... that it would be focusing on the relation between ... whole time//. ,Using tobacco or tobacco products is ... oral cancer. Smoking increases the chances of developing cancer ...
Cached Medicine News:Health News:Protective regimen for acute Graft-versus-host disease 2Health News:Fungal spores in the pillows can trigger an asthma attack 2Health News:Home Based Rapid HIV Test Kit to be approved by US – OraQuick Test Ki 2Health News:Increased Monitoring By Parents May Result In Lower BMI In Children 2
... 1000 assays are designed for ... IMMULITE 1000, continuous random access ... in both design and operation. ... in a wide variety of ...
... is devoid of any biological activity but ... structural integrity of insulin. Although insulin and ... equimolar concentrations, fasting levels of C-Peptide are ... owing to the longer half-life of C-Peptide. ...
Inquire...
Measles IgG ELISA test system is designed for the qualitative detection of IgG antibodies to Measles (Rubeola) virus in human serum, and is for in vitro diagnostic use....
Medicine Products: